Soheila Refahi

Soheila Refahi

Auto-generated profile, based on publicly available information

Soheila Refahi

Department of Medical Physics, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Medical Signals & Sensors
Verified
Journal Article
Open access
PDF file
BFBagher Farhood
Bagher Farhood
WPWrya Parwaie
Wrya Parwaie
SRSoheila Refahi
Soheila Refahi
MAMahdiehAfkhami Ardekani
MahdiehAfkhami Ardekani
With the advent of complex and precise radiation therapy techniques, the use of relatively small fields is needed. Using such field sizes can cause uncertainty in dosimetry; therefore, special attention is required both in dose calculations and measurements. There are several challenges in small-field dosimetry such as the steep gradient of the radiation field, volume averaging effect, lack of charged particle equilibrium, partial occlusion of radiation source, beam alignment, and unable to use a reference dosimeter. Due to these challenges, special dosimeters are needed for small-field dosimetry, and this review article discusses this topic.

23 December 2022 in Radiological Physics and Technology
Verified
Journal Article
Closed access
PDF file
NANikan Asadpour
Nikan Asadpour
RMReza Malekzadeh
Reza Malekzadeh
SRSaeed Rajabpour
Saeed Rajabpour
SRSoheila Refahi
Soheila Refahi
PMParinaz Mehnati
Parinaz Mehnati
ASAhmad Shanei
Ahmad Shanei

3 March 2020 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
AHAhmad Hormati
Ahmad Hormati
SASajjad Ahmadpour
Sajjad Ahmadpour
MAMahdieh Afkhami Ardekani
Mahdieh Afkhami Ardekani
FKFatemeh Khodadust
Fatemeh Khodadust
SRSoheila Refahi
Soheila Refahi

1 January 2015 in Journal of Medical Physics
Verified
Journal Article
Open access
PDF file
GHGholamHassan Hadadi
GholamHassan Hadadi
SRSoheila Refahi
Soheila Refahi
MPMasoud Pourissa
Masoud Pourissa
MZMohammad Reza Zirak
Mohammad Reza Zirak
To evaluate the ability of glycyrrhizic acid (GLA) to reduce the tumor necrosis factor α (TNF-α), release on messenger ribonucleic acid (mRNA) and protein production in the lungs using GLA in response to irradiation were studied. The animals were divided into four groups: No treatment (NT group), GLA treatment only (GLA group), irradiation only (XRT group), and GLA treatment plus irradiation (GLA/XRT group). Rats were killed at different time points. Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to evaluate the mRNA expression of TNF-α in the lungs (compared with non-irradiated lungs). An enzyme-linked immunosorbant assay (ELISA) assay was used to measure the TNF-α protein level. The TNF-α mRNA expression in the lungs of the XRT rats was clearly higher at all-time points compared to the NT rats. The TNF-α mRNA expression in the lungs of the GLA/XRT rats was lower at all-time points compared to the XRT rats. Release of the TNF-α on protein level in the lungs of the XRT rats increased at all-time points compared to the NT rats. In contrast to the XRT rats, the lungs of the GLA/XRT rats revealed a reduction on TNF-α protein level at 6 h after irradiation. This study has clearly showed the immediate down-regulation of the TNF-α mRNA and protein production in the lungs using GLA in response to irradiation.

21 March 2016 in Iranian Journal of Radiology
Verified
Journal Article
Open access
PDF file
SRSoheila Refahi
Soheila Refahi
BMBagher Minaei
Bagher Minaei
GHGholam Hassan Haddadi
Gholam Hassan Haddadi
SKSamideh Khoei
Samideh Khoei
ABAzam Bakhtiarian
Azam Bakhtiarian
ATAbbas Takavar
Abbas Takavar
Background: Radiotherapy of the thorax often causes lung inflammation leading to fibrosis. Objectives: The aim of this study was to investigate whether the use of glycyrrhizic acid (GLA) could improve the development of lung fibrosis in irradiated animals. Materials and Methods: Wistar rats were divided into four groups. Group A rats received thoracic irradiation. Rats in group B received GLA and irradiation. Group C received GLA and no irradiation. Group D received no GLA and irradiation. GLA was administered at a dose of 4 mg/kg body weight using an intraperitoneal injection one hour before thoracic irradiation. Radiation therapy was delivered on a Cobalt-60 unit using a single fraction of 16 Gy. The animals were sacrificed at 32 weeks following thoracic irradiation. The lungs were dissected and blind histopathological evaluation was performed. Results: Histopathologically, a decrease (statistically not significant) in the thickening of alveolar or bronchial wall, formation of fibrous bands, and superimposed collagen were noted in the animals in group B as compared to the animals in group A. Conclusion: In this experimental study, administration of GLA one hour before thoracic irradiation may be a protective agent against radiation-induced fibrosis in animals and this model could be used in future studies. Keywords: Lung fibrosis; Radioprotector; Glycyrrhizic Acid; Histopathology

24 April 2024 in Heliyon
Verified
Journal Article
Open access
MKMahtab Karami
Mahtab Karami
NHNasrin Hafizi
Nasrin Hafizi
ANAli Nickfarjam
Ali Nickfarjam
SRSoheila Refahi
Soheila Refahi
To reduce the risk of errors, patient safety monitoring in the medical imaging department is crucial. Interventions are required and these can be provided as a framework for documenting, reporting, evaluating, and recognizing events that pose a threat to patient safety. The aim of this study was to develop minimum data set and dashboard for monitoring adverse events in radiology departments. This developmental research was conducted in multiple phases, including content determination using the Delphi technique; database designing using SQL Server; user interface (UI) building using PHP; and dashboard evaluation in three aspects: the accuracy of calculating; UI requirements; and usability. This study identified 26 patient safety (PS) performance metrics and 110 PS-related significant data components organized into 14 major groupings as the system contents. The UI was built with three tabs: pre-procedure, intra-procedure, and post-procedure. The evaluation results proved the technical feasibility of the dashboard. Finally, the dashboard's usability was highly rated (76.3 out of 100). The dashboard can be used to supplement datasets to obtain a more accurate picture of the PS condition and to draw attention to characteristics that professionals might otherwise overlook or undervalue.